CHARM Therapeutics
Uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD124—185m (Dealroom.co estimates Apr 2023.)
Company register number 13641471
London England (HQ)
Financials
Estimates*
| USD | 2022 | 2023 |
|---|---|---|
| Revenues | 2.7m | 7.3m |
| % growth | - | 169 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | N/A | $12.6m | Early VC |
* | $50.0m | Series A | |
* | $20.0m | Early VC | |
| Total Funding | AUD128m | ||
Related Content
Recent News about CHARM Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.